Key points are not available for this paper at this time.
Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
Bloemberg et al. (Wed,) studied this question.